Physiological and pathological evidence of O-GlcNAcylation regulation during pregnancy related process
Placenta · 2023
DOI: 10.1016/j.placenta.2023.04.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Placenta, 2023. Verfasst von Marta de Lima Castro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduation Program in Health Sciences, Faculty of Medicine, Federal University of Goias, Goiânia, Brazil. Hauptthemen laut MEDLINE: Placenta, Epigenesis, Genetic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 147 Literaturangaben. Gefördert von: CAPES, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
O-GlcNAcylation is a dynamic and reversible post-translational modification (PTM) controlled by the enzymes O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA). Changes in its expression lead to a breakdown in cellular homeostasis, which is linked to several pathological processes. Placentation and embryonic development are periods of high cell activity, and imbalances in cell signaling pathways can result in infertility, miscarriage, or pregnancy complications. O-GlcNAcylation is involved in cellular processes such as genome maintenance, epigenetic regulation, protein synthesis/degradation, metabolic pathways, signaling pathways, apoptosis, and stress response. Trophoblastic differentiation/invasion and placental vasculogenesis, as well as zygote viability and embryonic neuronal development, are all dependent on O-GlcNAcylation. This PTM is required for pluripotency, which is a required condition for embryonic development. Further, this pathway is a nutritional sensor and cell stress marker, which is primarily measured by the OGT enzyme and its product, protein O-GlcNAcylation. Yet, this post-translational modification is enrolled in metabolic and cardiovascular adaptations during pregnancy. Finally, evidence of how O-GlcNAc impacts pregnancy during pathological conditions such as hyperglycemia, gestational diabetes, hypertension, and stress disorders are reviewed. Considering this scenario, progress in understanding the role of O- GlcNAcylation in pregnancy is required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduation Program in Health Sciences, Faculty of Medicine, Federal University of Goias, Goiânia, Brazil.
- Institute of Biological Sciences, Federal University of Goias, Goiânia, Brazil; Institute of Biological and Health Sciences, Federal University of Mato Grosso, Barra do Garças, Brazil.
- Institute of Biological Sciences, Federal University of Goias, Goiânia, Brazil; Institute of Biological and Health Sciences, Federal University of Mato Grosso, Barra do Garças, Brazil. Electronic address: fenandagiachin…
Förderung
- CAPES
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
de Lima Castro, M., Dos Passos, R. R., Justina, V. D., do Amaral, W. N., & Giachini, F. R. (2023). Physiological and pathological evidence of O-GlcNAcylation regulation during pregnancy related process. Placenta. https://doi.org/10.1016/j.placenta.2023.04.018
Vancouver
de Lima Castro M, Dos Passos RR, Justina VD, do Amaral WN, Giachini FR. Physiological and pathological evidence of O-GlcNAcylation regulation during pregnancy related process. Placenta. 2023. doi:10.1016/j.placenta.2023.04.018
BibTeX
@article{deLimaCastro2023,
author = {de Lima Castro, Marta and Dos Passos, Rinaldo Rodrigues and Justina, Vanessa Dela and do Amaral, Waldemar Naves and Giachini, Fernanda Regina},
title = {Physiological and pathological evidence of O-GlcNAcylation regulation during pregnancy related process},
journal = {Placenta},
year = {2023},
doi = {10.1016/j.placenta.2023.04.018}
}
EUVIMED